regulatory frameworks gene therapy regulators weigh risks potential benefits approving clinical trials therapies gene editing principle genetic alterations gametes embryos carried cells resulting child passed subsequent generations human gene pool examples proposed range avoidance severe inherited diseases enhancement human capabilities modifications human genomes include introduction naturally occurring variants totally novel genetic changes thought beneficial germ line editing poses important issues including risks inaccurate editing target mutations incomplete editing cells early stage embryos mosaicism ii difficulty predicting harmful effects genetic changes wide range circumstances experienced human population including interactions genetic variants environment iii obligation consider implications individual future generations carry genetic